Wat is de prijs voor Agile Therapeutics, Inc. (AGRX)

Het prijs van Agile Therapeutics, Inc. (AGRX) is $1.51

Wat is de marktkapitalisatie voor Agile Therapeutics, Inc. (AGRX)

Marktkapitalisatie voorAgile Therapeutics, Inc. (AGRX) is $1.12M

Agile Therapeutics, Inc. (AGRX) K/B-verhouding

Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.

Jaar	P/B-ratio	Wijzigen
2026 (TTM)	-0.20	-23.23%
2023	-0.26	-70.87%
2022	-0.88	-792.80%
2021	0.13	-97.41%
2020	4.93	82.38%
2019	2.70	175.75%
2018	0.98	-57.24%
2017	2.29	-39.87%
2016	3.81	-47.25%
2015	7.22	271.82%
2014	1.94	-377.53%
2013	-0.70	-17.96%
2012	-0.85	0.00%

Jaar

P/B-ratio

Wijzigen

2026 (TTM)

-0.20

-23.23%

2023

-0.26

-70.87%

2022

-0.88

-792.80%

2021

0.13

-97.41%

2020

4.93

82.38%

2019

2.70

175.75%

2018

0.98

-57.24%

2017

2.29

-39.87%

2016

3.81

-47.25%

2015

7.22

271.82%

2014

1.94

-377.53%

2013

-0.70

-17.96%

2012

-0.85

0.00%

Bedrijf	P/B-ratio	Verschil in P/B-ratio	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5.7207	-2,966.08%	IN

Bedrijf

P/B-ratio

Verschil in P/B-ratio

Land